Assyro AI

Orange Book product · Generic (ANDA)

AMPICILLIN SODIUM

AMPICILLIN SODIUM

Generic (ANDA)ANDA 202198TE APRX ONESOURCE SPECIALTY

At a glance

Apr 07, 2014

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 07, 2014

    12 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMPICILLIN SODIUM

Strength

EQ 10GM BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 202198

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMPICILLIN SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.